Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 1
1988 5
1989 2
1990 6
1991 11
1992 13
1993 12
1994 14
1995 3
1996 11
1997 12
1998 11
1999 15
2000 9
2001 9
2002 13
2003 13
2004 15
2005 18
2006 20
2007 22
2008 18
2009 18
2010 24
2011 11
2012 12
2013 14
2014 16
2015 12
2016 7
2017 11
2018 7
2019 10
2020 18
2021 17
2022 13
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

415 results

Results by year

Filters applied: . Clear all
Page 1
Vascular tumor targeting.
Ahlskog J, Paganelli G, Neri D. Ahlskog J, et al. Among authors: paganelli g. Q J Nucl Med Mol Imaging. 2006 Dec;50(4):296-309. Q J Nucl Med Mol Imaging. 2006. PMID: 17043627 Free article. Review.
PET/CT in Multiple Myeloma: Beyond FDG.
Matteucci F, Paganelli G, Martinelli G, Cerchione C. Matteucci F, et al. Among authors: paganelli g. Front Oncol. 2021 Jan 25;10:622501. doi: 10.3389/fonc.2020.622501. eCollection 2020. Front Oncol. 2021. PMID: 33569348 Free PMC article. Review.
Theragnostic in neuroendocrine tumors.
Marini I, Sansovini M, Bongiovanni A, Nicolini S, Grassi I, Ranallo N, Monti M, DI Iorio V, Germanò L, Caroli P, Sarnelli A, Paganelli G, Severi S. Marini I, et al. Among authors: paganelli g. Q J Nucl Med Mol Imaging. 2021 Dec;65(4):342-352. doi: 10.23736/S1824-4785.21.03426-9. Epub 2021 Dec 9. Q J Nucl Med Mol Imaging. 2021. PMID: 34881852
Yttrium-based therapy for neuroendocrine tumors.
Bodei L, Cremonesi M, Paganelli G. Bodei L, et al. Among authors: paganelli g. PET Clin. 2014 Jan;9(1):71-82. doi: 10.1016/j.cpet.2013.10.001. PET Clin. 2014. PMID: 25029936 Review.
Radioligand therapies in cancer: mapping the educational landscape in Europe.
Bugani V, Battistelli L, Sansovini M, Monti M, Paganelli G, Gich I, Flotats A, Erba PA, Blay JY, la Fougère C, Van Poppel H, Charalambous A, Herrmann K, Giordano A, Györke T, Deroose C, Matteucci F, Carrió I. Bugani V, et al. Among authors: paganelli g. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2692-2698. doi: 10.1007/s00259-023-06217-0. Epub 2023 Apr 14. Eur J Nucl Med Mol Imaging. 2023. PMID: 37058168 Free PMC article.
Pretargeted radioimmunotherapy.
Paganelli G. Paganelli G. Ernst Schering Res Found Workshop. 2005;(49):73-84. doi: 10.1007/3-540-26809-x_4. Ernst Schering Res Found Workshop. 2005. PMID: 15524211 Review. No abstract available.
Targeted radioactive therapy for prostate cancer.
De Giorgi U, Conteduca V, Gurioli G, Matteucci F, Paganelli G. De Giorgi U, et al. Among authors: paganelli g. Lancet. 2021 Aug 7;398(10299):487-488. doi: 10.1016/S0140-6736(21)01336-2. Lancet. 2021. PMID: 34364517 No abstract available.
CAR-T cell therapy: a potential new strategy against prostate cancer.
Schepisi G, Cursano MC, Casadei C, Menna C, Altavilla A, Lolli C, Cerchione C, Paganelli G, Santini D, Tonini G, Martinelli G, De Giorgi U. Schepisi G, et al. Among authors: paganelli g. J Immunother Cancer. 2019 Oct 16;7(1):258. doi: 10.1186/s40425-019-0741-7. J Immunother Cancer. 2019. PMID: 31619289 Free PMC article. Review.
415 results